Pfizer
-
World
Pfizer, BioNTech start late-stage clinical trial of COVID vax
New York: US-based Pfizer and German biotech firm BioNTech have announced the start of a late-stage clinical trial of a COVID-19 vaccine jointly developed by the two companies. The Phase 2/3…
Read More » -
Business
Pfizer acquires Array Biopharma, valued at $11.4 billion
NEW YORK: US pharmaceutical giant Pfizer on Monday announced the acquisition of Array BioPharma, a biotechnology firm that specializes in cancer drugs, the latest in a long list of biotech…
Read More »
